Synergy Pharmaceuticals, Inc. (SGYP) News - Find the latest company news headlines for Synergy Pharmaceuticals, Inc.
SGYPQ SEC Filings - SYNERGY PHARMACEUTICALS INC DEL- Annual Report, Proxy Statement, Prospectus.
The Company was selected as the successful bidder to acquire certain assets of Synergy Pharmaceuticals Inc. (NASD: SGYP) (Synergy) for a cash purchase price of
Synergy Pharmaceuticals Inc. The structure of this financing provides us with access to capital for support of our commercialization of
New York-based Synergy Pharmaceuticals Inc. granted Shandong Luoxin Pharmaceutical Group Stock Co. Ltd. an exclusive license to develop and
The Company has completed the acquisition of certain assets of Synergy Pharmaceuticals Inc. (NASD: SGYP) (Synergy) for a cash purchase price of approximately $
On, Synergy Pharmaceuticals Inc. went out of business on completion of liquidation under chapter 11 bankruptcy filing. Synergy Pharmaceuticals Inc, a biopharmaceutical company
SYNERGY PHARMACEUTICALS INC DEL (SGYP.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock SYNERGY PHARMACEUTICALS INC DEL
NEW YORK, CEST (GLOBE NEWSWIRE) - Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat
Comments